Recommanded Tools
AbSeek™ encompasses antibody sequence analysis, structure and function prediction, lead optimization, de novo generation, and visualization, among others, covering all stages of antibody discovery and engineering from screening to optimization for efficient innovation.
Free Tools Limited Time
Sequence Analysis
Function Prediction
Lead Optimization
Structure Prediction
New
Molecule Generation

Features & Advantages
Integration
Combines multiple algorithms to provide a one-stop service that meets all needs in antibody discovery and engineering.
Expertise
Tailors UI and data visualization methods based on the characteristics of antibody data for better suitability.
Advancement
Continuously updates cutting-edge AI algorithms to ensure the platform's timeliness and advancement.
Data Security
Committed to providing users with a secure and reliable data environment, alleviating concerns about data leakage.
News
Cyagen Talk|AI-Powered Antibody Discovery: From HUGO-Ab Mice to Predictive Models
AbSeek™: Intelligent Antibody Computational Platform
2025-03-19
More >>【Frontier Express】Advanced Science | B7-H3/NETs Dual-Targeting Hydrogel Remodels Tumor Immune Microenvironment to Enhance OSCC Immunotherapy
2026-04-16
【Frontier Express】Advanced Science | PD-L1-Binding Antigen Presenters Redirect Vaccine-Induced Antibodies for Cancer Immunotherapy
2026-04-15
【Frontier Express】Nature Communications | Multi-omics Molecular Profiling Reveals New Diagnostic and Targeted Therapeutic Strategies for DSRCT
2026-04-15
【Frontier Express】Circulation Research | MIR181A1HG Regulates Endothelial Inflammation and Atherosclerosis Through a Molecular Trap Mechanism
2026-04-14
【Frontier Express】Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology | Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in RAS/BRAF Wild-Type HER2-Positive Metastatic Colorectal Cancer
2026-04-13
【Frontier Express】Cancer Discovery | Circulating Tumor Cells Predict Efficacy of DLL3-Targeting Bispecific Antibody Tarlatamab in Small Cell Lung Cancer
2026-04-13
【Frontier Express】Science Translational Medicine | Epigenetic Dysregulation of Metabolic Programs Drives Cell Plasticity in Liposarcoma
2026-04-12






